# | Drug | Count |
---|---|---|
0 | ADALIMUMAB | 98 |
1 | ETANERCEPT | 68 |
2 | RITUXIMAB | 68 |
3 | ABATACEPT | 67 |
4 | TOCILIZUMAB | 67 |
5 | INFLIXIMAB | 66 |
6 | METHOTREXATE SODIUM | 66 |
7 | LEFLUNOMIDE | 65 |
8 | SULFASALAZINE | 65 |
9 | TOFACITINIB | 63 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | GOLD | 42 | 0.0106 |
1 | CANAKINUMAB | 41 | 0.0051 |
2 | MINOCYCLINE HYDROCHLORIDE | 40 | 0.0037 |
3 | ANAKINRA | 42 | 0.0036 |
4 | ACETYLSALICYCLIC ACID | 1 | 0.0034 |
5 | DOXYCLYCLINE HYCLATE | 17 | 0.0017 |
6 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0011 |
7 | SULFASALAZINE | 65 | 0.0011 |
8 | TOCILIZUMAB | 67 | 0.0008 |
9 | HYDROXYCHLOROQUINE SULFATE | 60 | 0.0008 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Interleukin-1 Receptor Antagonist [EPC] | 42 | 0.0036 |
1 | Standardized Chemical Allergen [EPC] | 42 | 0.0034 |
2 | Antirheumatic Agent [EPC] | 65 | 0.0008 |
3 | Interleukin-6 Receptor Antagonist [EPC] | 67 | 0.0008 |
4 | Aminosalicylate [EPC] | 65 | 0.0007 |
5 | Selective T Cell Costimulation Modulator [EPC] | 67 | 0.0007 |
6 | Tetracycline-class Drug [EPC] | 24 | 0.0005 |
7 | CD20-directed Cytolytic Antibody [EPC] | 69 | 0.0004 |
8 | Anticholinergic [EPC] | 3 | 0.0003 |
9 | GLP-2 Analog [EPC] | 2 | 0.0002 |